Beta-blockade in Unruptured Intracranial Aneurysm
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.
Also called NCT06249802
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT06249802
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Poland
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06249802. Randomized; quadruple masking; primary purpose prevention. Start 2025-01-01 (anticipated); primary completion 2029-01-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Beta-blockade in Unruptured Intracranial Aneurysm
- Acronym
- BBLURAN
- Condition
- Intracranial Aneurysm
- Intervention (Drug)
- Nebivolol
- Intervention (Drug)
- Placebo
- Lead sponsor
- Jagiellonian University
- Collaborator
- University Hospital in Krakow
Record details
- Record id
cardio:ct-nct06249802- Content hash
5444875cf5ccab2b83709d9e02629ca8a236fe0c98833449f8c43c28c2023d83